Jacopo Oieni
Post Doctoral Scientist
Post Doctoral Scientist
I completed my Ph.D. in 2020 at Technion – Israel Institute of Technology, Israel in nanotechnology, on the delivery of antisense oligonucleotides with biomimetic nanovesicles for osteoarthritis treatment.
As a Postdoctoral research assistant, I joined Professor Matthew Wood’s group to study the therapeutic potential of antisense oligonucleotides in neuromuscular diseases. In particular, in collaboration with Takeda Pharmaceutical, I am interested in developing new antisense oligonucleotides for Duchenne Muscular Dystrophy (DMD).